These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

7234 related items for PubMed ID: 3093425

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Augmented antitumor effect of recombinant human interleukin-1 alpha by indomethacin.
    Nakata K, Kashimoto S, Yoshida H, Oku T, Nakamura S.
    Cancer Res; 1988 Feb 01; 48(3):584-8. PubMed ID: 3257168
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T, Shimomura K, Mukumoto S, Kobayashi K, Mizota T, Hirai O, Matsumoto S, Oku T, Nishigaki F, Mori J.
    Cancer Res; 1987 Jul 15; 47(14):3707-11. PubMed ID: 3594435
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of recombinant human interferon-alpha A/D on the growth of experimental tumors in mice].
    Ootsu K, Kozai Y, Houkan T, Gotoh K, Matsutani E.
    Gan To Kagaku Ryoho; 1987 Aug 15; 14(8):2502-8. PubMed ID: 3304169
    [Abstract] [Full Text] [Related]

  • 9. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
    Asher A, Mulé JJ, Reichert CM, Shiloni E, Rosenberg SA.
    J Immunol; 1987 Feb 01; 138(3):963-74. PubMed ID: 3805720
    [Abstract] [Full Text] [Related]

  • 10. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
    Nakata K, Yoshida H, Kashimoto S, Sohmura Y, Nakamura S, Taguchi T.
    Gan To Kagaku Ryoho; 1986 Oct 01; 13(11):3186-93. PubMed ID: 3096217
    [Abstract] [Full Text] [Related]

  • 11. [Antitumor effect of human recombinant interferon-alpha A/D in mice(I): Comparison between systemic and lesional treatment of meth-A sarcoma in BALB/c mice].
    Nanjo M, Yoshie O, Aso H, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1985 Mar 01; 12(3 Pt 1):505-9. PubMed ID: 4004283
    [Abstract] [Full Text] [Related]

  • 12. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.
    Mulé JJ, Ettinghausen SE, Spiess PJ, Shu S, Rosenberg SA.
    Cancer Res; 1986 Feb 01; 46(2):676-83. PubMed ID: 3484431
    [Abstract] [Full Text] [Related]

  • 13. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.
    Berman RM, Suzuki T, Tahara H, Robbins PD, Narula SK, Lotze MT.
    J Immunol; 1996 Jul 01; 157(1):231-8. PubMed ID: 8683120
    [Abstract] [Full Text] [Related]

  • 14. Effect of recombinant interleukin-1 alpha, recombinant interleukin-2, recombinant interferon-beta, and recombinant tumor necrosis factor on subcutaneously implanted adenocarcinoma 755 and Lewis lung carcinoma.
    Iigo M, Nishikata K, Hoshi A.
    J Biol Response Mod; 1990 Aug 01; 9(4):426-30. PubMed ID: 2395006
    [Abstract] [Full Text] [Related]

  • 15. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K, Tanaka T, Takeuchi M.
    Cancer Treat Rep; 1985 Mar 01; 69(3):285-91. PubMed ID: 3978657
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Successful immunotherapy of mouse melanoma and sarcoma with recombinant interleukin-2 and cyclophosphamide.
    Silagi S, Schaefer AE.
    J Biol Response Mod; 1986 Oct 01; 5(5):411-22. PubMed ID: 3490544
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
    Haranaka K, Sakurai A, Satomi N.
    J Biol Response Mod; 1987 Aug 01; 6(4):379-91. PubMed ID: 3625230
    [Abstract] [Full Text] [Related]

  • 20. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh].
    Komiyama K, Hirokawa Y, Zhibo Y, Umezawa I, Hata T.
    Gan To Kagaku Ryoho; 1988 May 01; 15(5):1715-9. PubMed ID: 3130806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 362.